Tilray Brands Files 8-K on Financials

Ticker: TLRY · Form: 8-K · Filed: 2025-07-28T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, results-of-operations, filing

TL;DR

Tilray Brands dropped an 8-K on July 28, 2025, with financial updates. Check it out.

AI Summary

On July 28, 2025, Tilray Brands, Inc. filed an 8-K report to disclose information regarding its results of operations and financial condition. The filing also includes financial statements and exhibits, providing an update on the company's financial performance and business activities.

Why It Matters

This 8-K filing provides investors with crucial, up-to-date information on Tilray Brands' financial health and operational performance, impacting investment decisions.

Risk Assessment

Risk Level: medium — 8-K filings can contain significant financial and operational updates that may impact a company's stock price and investor confidence.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Tilray Brands, Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.

What is the exact date of the report?

The exact date of the report is July 28, 2025.

What is Tilray Brands, Inc.'s SEC file number?

Tilray Brands, Inc.'s SEC file number is 001-38594.

What is the company's principal executive office address?

The company's principal executive office is located at 265 Talbot Street West, Leamington, Ontario, N8H 4H3.

What is the registrant's telephone number?

The registrant's telephone number is (844) 845-7291.

From the Filing

0001171843-25-004746.txt : 20250728 0001171843-25-004746.hdr.sgml : 20250728 20250728163241 ACCESSION NUMBER: 0001171843-25-004746 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250728 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250728 DATE AS OF CHANGE: 20250728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 251156037 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 8-K 1 f8k_072825.htm FORM 8-K Form 8-K False 0001731348 0001731348 2025-07-28 2025-07-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________ FORM 8-K _________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  July 28, 2025 _______________________________ Tilray Brands, Inc. (Exact name of registrant as specified in its charter) _______________________________ Delaware 001-38594 82-4310622 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 265 Talbot Street West Leamington , Ontario   N8H 4H3 (Address of Principal Executive Offices) (Zip Code) ( 844 ) 845-7291 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) _______________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.0001 per share TLRY The NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐     Item 2.02. Results of Operations and Financial Condition.   On July 28, 2025, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.   Item 9.01. Financial Statements and Exhibits.   (d) Exhibits   Exhibit Number   Description       99.1   Press Release dated July 28, 2025 104   Cover Page Interactive Data File (embedded within the Inline XBRL document)       SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the reg

View on Read The Filing